US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
The imposition of tariffs threatens to elevate costs, creating uncertainty in launch planning, particularly for late-stage assets…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US tariffs
Industry reacts to Trump’s 25 per cent tariff penalty, highlighting its implications on pharma
While the immediate consequences of these tariffs will likely result in increased costs for essential drugs, the long-term impact…
Pharma CRDMO revenue forecasts 13-15 per cent growth amid supply-chain derisking
Resultant strong cash flows will enable Indian CRDMOs to continue capital expenditure (capex), with limited reliance on debt…
Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access,…
US pharma manufacturing sees investment surge amid tariff shifts, while BRICS nations push regulatory reforms to expand biosimilar…
US tariffs, IP issues threaten patient access
The judgements on the Roche Natco case for SMA medicine risdiplam could impact petitions from patients suffering from other rare…